Protecting research subjects--the crisis at Johns Hopkins

N Engl J Med. 2002 Feb 28;346(9):716-20. doi: 10.1056/NEJM200202283460924.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Academic Medical Centers
  • Adult
  • Asthma / physiopathology*
  • Baltimore
  • Clinical Trials as Topic / standards*
  • Ethics Committees, Research
  • Fatal Outcome
  • Federal Government
  • Female
  • Financing, Government
  • Ganglionic Blockers / adverse effects*
  • Ganglionic Blockers / pharmacology
  • Government Regulation*
  • Hexamethonium / adverse effects*
  • Hexamethonium / pharmacology
  • Human Experimentation* / economics
  • Human Experimentation* / legislation & jurisprudence
  • Humans
  • National Institutes of Health (U.S.)
  • Research Support as Topic
  • United States
  • United States Food and Drug Administration

Substances

  • Ganglionic Blockers
  • Hexamethonium